Sanjay Popat

机构：Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Inserm, Université de Lille, Cancer Research UK, Centre Hospitalier Universitaire de Lille, Institute of Cancer Research, Sutton Hospital, Royal Marsden Hospital, Centre de Recherche en Cancérologie de Lyon, Onco Lille, CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers, Imperial College London · ORCID：0000-0003-2087-4963

发表论文 838 篇 · 总被引 31154 次 · h-index 63

代表论文

• Evolutionary characterization of lung cancer metastasis (2026 · Nature · 被引 5)
• Abstract CT215: RASolve 301: A Phase 3 study of daraxonrasib (RMC-6236) vs. docetaxel in patients with previously treated RAS-mutant NSCLC (2026 · Cancer Research · 被引 2)
• Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study (2026 · The Lancet Oncology · 被引 1)
• Efficacy and safety of pralsetinib as first-line treatment of RET fusion–positive advanced or metastatic non–small cell lung cancer (NSCLC): The phase 3 AcceleRET-Lung study. (2026 · Journal of Clinical Oncology · 被引 1)
• Metastatic Trajectories in Non–Small Cell Lung Cancer Guide Local and Systemic Therapies (2026 · Journal of Clinical Oncology · 被引 1)
• Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives (2026 · Lung Cancer)